Southland Equity Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Southland Equity Partners’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$560K	Buy	+10,337	New	+$465K	0.1%	150

Other funds holding ARKG

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return

CFIM

Client First Investment Management West Bend, Wisconsin $210M AUM 50.85% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $146M AUM 18.19% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Lauer Wealth Valparaiso, Indiana $160M AUM 11.89% 1-Year Est. Return

Dynamic Advisor Solutions Phoenix, Arizona $3.52B AUM 15.33% 1-Year Est. Return

TAM

Titleist Asset Management San Antonio, Texas $1.55B AUM 13.34% 1-Year Est. Return

HCA

Heck Capital Advisors Rhinelander, Wisconsin $1.82B AUM 17.91% 1-Year Est. Return

Southland Equity Partners's ARKG Position: Q3 2026 in Review

Southland Equity Partners opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 10,337 shares worth $560K. The stake represents 0.1% of the portfolio and ranks #150 among its holdings.

22 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

Southland Equity Partners held 10,337 shares of ARK Genomic Revolution ETF worth $560K as of Q3 2026.
ARK Genomic Revolution ETF was a new Southland Equity Partners position in Q3 2026.
ARK Genomic Revolution ETF made up 0.1% of Southland Equity Partners's portfolio in Q3 2026, its #150 holding.
22 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Southland Equity Partners's 13F filing for Q3 2026, filed 14 Oct 2026.